etoposide has been researched along with mangiferin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Fang, J; Li, SS; Yang, LJ; Zeng, LL; Zhang, BP; Zhao, J | 1 |
| Chen, Y; Fang, J; Li, S; Zeng, L; Zhang, B; Zhao, J | 1 |
2 other study(ies) available for etoposide and mangiferin
| Article | Year |
|---|---|
Mangiferin activates Nrf2-antioxidant response element signaling without reducing the sensitivity to etoposide of human myeloid leukemia cells in vitro.
Topics: Antioxidant Response Elements; Cell Line, Tumor; Etoposide; HL-60 Cells; Humans; Leukemia, Myeloid; NF-E2-Related Factor 2; Signal Transduction; Xanthones | 2014 |
Mangiferin activates the Nrf2-ARE pathway and reduces etoposide-induced DNA damage in human umbilical cord mononuclear blood cells.
Topics: Antineoplastic Agents, Phytogenic; Antioxidant Response Elements; Antioxidants; Comet Assay; DNA Damage; Electrophoretic Mobility Shift Assay; Etoposide; Female; Fetal Blood; Humans; Leukocytes, Mononuclear; Micronuclei, Chromosome-Defective; Micronucleus Tests; Microscopy, Confocal; NF-E2-Related Factor 2; Protein Binding; Signal Transduction; Xanthones | 2015 |